Who Buys Natural from India — 742 Importers Behind a $25.5M Market
India's natural import market is served by 742 active buyers who collectively imported $25.5M across 3,891 shipments. SHALINA HEALTHCARE NIGERIA LTD (NIGERIA) leads with a 10.4% market share, followed by AMBICA INTERNATIONAL CORPORATION and ARROW PHARMACEUTICALS PTY LTD,. The top 5 buyers together control 31.2% of total import value, reflecting a moderately competitive buyer landscape.
Top Natural Importers — Ranked by Import Value
SHALINA HEALTHCARE NIGERIA LTD (NIGERIA) is the leading natural importer from India, holding a 10.4% share of the $25.5M market across 3,891 shipments from 742 buyers. The top 5 buyers — SHALINA HEALTHCARE NIGERIA LTD (NIGERIA), AMBICA INTERNATIONAL CORPORATION (PHILIPPINES), ARROW PHARMACEUTICALS PTY LTD, (AUSTRALIA), ARROW PHARMACEUTICALS PTY LTD (AUSTRALIA), ARROW PHARMACEUTICALS PTY LTD., (AUSTRALIA) — collectively control 31.2% of total import value.
Top Natural Buyers & Importers
Ranked by import value · 742 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | SHALINA HEALTHCARE NIGERIA LTDNIGERIA MENTHOL CRYSTALS BPH/M-SHALTOUX NATURAL LOZ 3X4X20 E/F/PSHALTOUX NATURAL LOZ 3X4X20 E/F/P996/ | $2.7M | 5 | 10.4% |
| 2 | AMBICA INTERNATIONAL CORPORATIONPHILIPPINES | $1.8M | 5 | 7.0% |
| 3 | ARROW PHARMACEUTICALS PTY LTD,AUSTRALIA MACROVIC MACROGOL NATURAL [13.71G] [SACH | $1.4M | 5 | 5.4% |
| 4 | ARROW PHARMACEUTICALS PTY LTDAUSTRALIA MACROVIC MACROGOL NATURAL [13.71G] [SACH | $1.2M | 5 | 4.5% |
| 5 | ARROW PHARMACEUTICALS PTY LTD.,AUSTRALIA MACROVIC MACROGOL NATURAL [13.71G] [SACH | $974.4K | 5 | 3.8% |
| 6 | SHALINA HEALTHCARE GHANA LIMITEDGHANA MENTHOL CRYSTALS BPH/M-SHALTOUX NATURAL LOZ 3X4X20 E/F/PSHALTOUX NATURAL LOZ 3X4X20 E/F/P996/ | $932.9K | 5 | 3.7% |
| 7 | BSN MEDICAL(AUST.) PTY LTDAUSTRALIA MACROVIC MACROGOL NATURAL [13.71G] [SACH | $894.2K | 5 | 3.5% |
| 8 | JAMP PHARMA CORPORATIONCANADA JAMP SENNA 8.6 MG NATURAL-TABLET 500'S BOTTELJAMP SENNA 8.6MG NATURAL-TABLET 500'S BOJAMP SENNA 8.6 MG NATURAL-TABLET 500'S B | $840.7K | 5 | 3.3% |
| 9 | BSN MEDICAL AUST PTY LTDAUSTRALIA MACROVIC MACROGOL NATURAL [13.71G] [SACH | $525.3K | 5 | 2.1% |
| 10 | ARROW PHARMACEUTICALS PTY LIMITEDAUSTRALIA MACROVIC MACROGOL NATURAL [13.71G] [SACH | $502.1K | 5 | 2.0% |
| 11 | BSN MEDICAL LTDNEW ZEALAND MACROVIC MACROGOL NATURAL [13.71G] [SACH | $452.9K | 5 | 1.8% |
| 12 | SHALINA PHARMACEUTICALS ZAMBIA LTDZAMBIA MENTHOL CRYSTALS BPH/M-SHALTOUX NATURAL LOZ 3X4X20 E/F/PSHALTOUX NATURAL LOZ 3X4X20 E/F/P996/ | $407.6K | 5 | 1.6% |
| 13 | EAST MIDLANDS PHARMA LTDUNITED KINGDOM NATURAL MENTHOL CRYSTALS USPMENTHOL CRYSTALS NATURALMENTHOL CRYSTAL, NATURAL | $366.4K | 5 | 1.4% |
| 14 | AFRICA PHARMACY LIMITADAANGOLA | $324.0K | 5 | 1.3% |
| 15 | M/S HIND AROMA & EXTRACTS INCUNITED STATES MENTHOL CRYSTALS BPNATURAL MENTHOL CRYSTALS USPMACROVIC MACROGOL NATURAL [13.71G] [SACH | $285.5K | 5 | 1.1% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Natural — and from which countries?
Flow of Natural exports from India: each country's share and the named importers behind the numbers
Natural — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Australia
Australia emerges as the first largest importing country, achieving a total trade value of $5.9M through 190 shipments. This represents a market share of 23.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• ARROW PHARMACEUTICALS PTY LTD, - $1.4M (23.6% of country's total business)
• ARROW PHARMACEUTICALS PTY LTD - $1.2M (19.7% of country's total business)
• ARROW PHARMACEUTICALS PTY LTD., - $974.4K (16.6% of country's total business)
• BSN MEDICAL(AUST.) PTY LTD - $894.2K (15.3% of country's total business)
• BSN MEDICAL AUST PTY LTD - $525.3K (9.0% of country's total business)
• Rest of Australia's importers - $926.4K (15.8% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $30.9K, indicating premium pricing strategy compared to the market average of $6.6K.
Australia is a key market for Natural imports, representing 23.0% of total trade value.
2Nigeria
Nigeria emerges as the second largest importing country, achieving a total trade value of $3.5M through 199 shipments. This represents a market share of 13.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nigeria has a diverse importer base, with their top importers including:
• SHALINA HEALTHCARE NIGERIA LTD - $2.7M (75.7% of country's total business)
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $17.7K, indicating premium pricing strategy compared to the market average of $6.6K.
Nigeria is a key market for Natural imports, representing 13.8% of total trade value.
3United States
United States emerges as the third largest importing country, achieving a total trade value of $2.4M through 4 shipments. This represents a market share of 9.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• M/S HIND AROMA & EXTRACTS INC - $285.5K (11.8% of country's total business)
• HIND AROMA & EXTRACTS INC - $282.0K (11.7% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $604.2K, indicating premium pricing strategy compared to the market average of $6.6K.
United States is a key market for Natural imports, representing 9.5% of total trade value.
4Philippines
Philippines emerges as the fourth largest importing country, achieving a total trade value of $1.8M through 12 shipments. This represents a market share of 7.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• AMBICA INTERNATIONAL CORPORATION - $1.8M (100.0% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $149.5K, indicating premium pricing strategy compared to the market average of $6.6K.
Philippines is a key market for Natural imports, representing 7.0% of total trade value.
5Hong Kong
Hong Kong emerges as the fifth largest importing country, achieving a total trade value of $1.4M through 0 shipments. This represents a market share of 5.5% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Hong Kong demonstrates strong market positioning with an average shipment value of $1.4M, indicating premium pricing strategy compared to the market average of $6.6K.
Hong Kong is a key market for Natural imports, representing 5.5% of total trade value.
Buyer Segment Analysis
TransData Nexus Natural buyer market intelligence
1Buyer Segment Analysis
The 742 buyers of "Natural" from India can be categorized into several segments:
1. Distributors: Entities that purchase large quantities to supply to various retailers or healthcare providers. For instance, SHALINA HEALTHCARE NIGERIA LTD, the top buyer with imports totaling $2.67 million, likely operates as a distributor, supplying to multiple outlets across Nigeria.
2. Hospital Groups: Large healthcare institutions procuring directly for patient care. While specific hospital groups are not identified among the top buyers, it's common for such entities to engage in direct procurement to ensure a steady supply of essential medicines.
3. Retail Chains: Pharmacy chains that purchase to stock their outlets. AMBICA INTERNATIONAL CORPORATION from the Philippines, with imports worth $1.79 million, may represent this segment, supplying to a network of retail pharmacies.
4. Government Procurement: Organizations like UNICEF, the Global Fund, or national health ministries that procure for public health programs. While not explicitly listed among the top buyers, such entities often engage in bulk purchasing through tenders to support national healthcare initiatives.
5. Re-exporters: Companies that import products to export them to other markets. Hong Kong, accounting for 5.5% of imports, serves as a significant re-export hub, indicating the presence of such buyers.
6. Contract Manufacturers: Firms that import raw materials or semi-finished products for further processing. ARROW PHARMACEUTICALS PTY LTD from Australia, with combined imports exceeding $3 million, may fall into this category, engaging in local manufacturing or packaging.
Country-Specific Import Regulations
TransData Nexus Natural buyer market intelligence
1Country-Specific Import Regulations
Australia
1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).
2. Import Registration Process: Importers must register the product with the TGA, providing comprehensive data on quality, safety, and efficacy.
3. Estimated Timeline for Registration: Typically 6-12 months, depending on the complexity of the application.
4. Import Tariff/Duty for HS 30049011: Under the Australia-Hong Kong Free Trade Agreement (A-HKFTA), certain pharmaceutical products may benefit from preferential tariff treatment. Importers should consult the Australian Department of Foreign Affairs and Trade for specific tariff rates. (dfat.gov.au)
Nigeria
1. Drug Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
2. Import Registration Process: Requires submission of an application with product dossiers, including manufacturing details and clinical data.
3. Estimated Timeline for Registration: Approximately 6-9 months.
4. Import Tariff/Duty for HS 30049011: Import duties vary; importers should refer to the Nigeria Customs Service for current rates.
United States
1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure the product is FDA-approved and comply with labeling and manufacturing standards. Affirmation of Compliance codes, such as Drug Registration Number (REG) and Drug Listing Number (DLS), are used to facilitate FDA review.
3. Estimated Timeline for Registration: Varies; new drug applications can take several months to years.
4. Import Tariff/Duty for HS 30049011: Pharmaceutical products under this HS code are generally duty-free.
Philippines
1. Drug Regulatory Authority: Food and Drug Administration Philippines.
2. Import Registration Process: Requires submission of product dossiers, including Certificates of Product Registration and Good Manufacturing Practice certificates.
3. Estimated Timeline for Registration: Approximately 6-12 months.
4. Import Tariff/Duty for HS 30049011: Tariff rates vary; importers should consult the Philippine Tariff Commission for specific rates.
Hong Kong
1. Drug Regulatory Authority: Department of Health, Drug Office.
2. Import Registration Process: Importers must obtain a Certificate of Drug Registration, providing details on product quality and safety.
3. Estimated Timeline for Registration: Approximately 6-9 months.
4. Import Tariff/Duty for HS 30049011: Hong Kong maintains a free port status with no import tariffs on pharmaceutical products.
Demand Drivers & Market Opportunity
TransData Nexus Natural buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for "Natural" in importing countries is influenced by several factors:
1. Disease Prevalence: High incidence of conditions treatable by "Natural" drives demand. For example, in regions with prevalent neglected tropical diseases, access to essential medicines is crucial.
2. Government Healthcare Programs: Initiatives aimed at expanding universal health coverage (UHC) increase the need for essential medicines. Countries implementing UHC strive to ensure equitable access to quality healthcare, including essential medicines.
3. WHO Essential Medicines List Procurement: Inclusion of "Natural" in the WHO Essential Medicines List encourages procurement by governments and international organizations, ensuring availability in public health systems.
4. Tender-Based Purchasing: Many countries and organizations utilize tender systems for bulk purchasing of medicines, promoting competitive pricing and consistent supply. Effective public procurement procedures are essential for timely access to health technologies. (who.int)
With 742 buyers across 132 countries, the market for "Natural" demonstrates significant global reach and potential for growth, especially in regions prioritizing healthcare access and affordability.
Common Questions — Natural Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest natural buyer importing from India?
Based on import volume and value, SHALINA HEALTHCARE NIGERIA LTD (NIGERIA) leads with $2.7M in imports and a 10.4% market share — the highest of any single natural importer. AMBICA INTERNATIONAL CORPORATION (PHILIPPINES) and ARROW PHARMACEUTICALS PTY LTD, (AUSTRALIA) are the next largest buyers.
QHow many companies buy natural from India?
There are 742 active natural buyers importing from India, with a combined market of $25.5M across 3,891 shipments to 132 countries. The top 5 buyers hold 31.2% of total import value, while the remaining 737 buyers handle the other 68.8%.
QWhich countries import the most natural from India?
The top importing countries for natural from India are Australia (23.0%), Nigeria (13.8%), United States (9.5%), Philippines (7.0%), Hong Kong (5.5%). These markets represent the largest demand centres for Indian pharmaceutical exports of natural, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for natural from India?
The average import transaction value for natural from India is $6.6K, with an average unit price of $6.61 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Natural buyer market intelligence
1Buyer Segment Analysis
The 742 buyers of "Natural" from India can be categorized into several segments:
1. Distributors: Entities that purchase large quantities to supply to various retailers or healthcare providers. For instance, SHALINA HEALTHCARE NIGERIA LTD, the top buyer with imports totaling $2.67 million, likely operates as a distributor, supplying to multiple outlets across Nigeria.
2. Hospital Groups: Large healthcare institutions procuring directly for patient care. While specific hospital groups are not identified among the top buyers, it's common for such entities to engage in direct procurement to ensure a steady supply of essential medicines.
3. Retail Chains: Pharmacy chains that purchase to stock their outlets. AMBICA INTERNATIONAL CORPORATION from the Philippines, with imports worth $1.79 million, may represent this segment, supplying to a network of retail pharmacies.
4. Government Procurement: Organizations like UNICEF, the Global Fund, or national health ministries that procure for public health programs. While not explicitly listed among the top buyers, such entities often engage in bulk purchasing through tenders to support national healthcare initiatives.
5. Re-exporters: Companies that import products to export them to other markets. Hong Kong, accounting for 5.5% of imports, serves as a significant re-export hub, indicating the presence of such buyers.
6. Contract Manufacturers: Firms that import raw materials or semi-finished products for further processing. ARROW PHARMACEUTICALS PTY LTD from Australia, with combined imports exceeding $3 million, may fall into this category, engaging in local manufacturing or packaging.
Country-Specific Import Regulations
TransData Nexus Natural buyer market intelligence
1Country-Specific Import Regulations
Australia
1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).
2. Import Registration Process: Importers must register the product with the TGA, providing comprehensive data on quality, safety, and efficacy.
3. Estimated Timeline for Registration: Typically 6-12 months, depending on the complexity of the application.
4. Import Tariff/Duty for HS 30049011: Under the Australia-Hong Kong Free Trade Agreement (A-HKFTA), certain pharmaceutical products may benefit from preferential tariff treatment. Importers should consult the Australian Department of Foreign Affairs and Trade for specific tariff rates. (dfat.gov.au)
Nigeria
1. Drug Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
2. Import Registration Process: Requires submission of an application with product dossiers, including manufacturing details and clinical data.
3. Estimated Timeline for Registration: Approximately 6-9 months.
4. Import Tariff/Duty for HS 30049011: Import duties vary; importers should refer to the Nigeria Customs Service for current rates.
United States
1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure the product is FDA-approved and comply with labeling and manufacturing standards. Affirmation of Compliance codes, such as Drug Registration Number (REG) and Drug Listing Number (DLS), are used to facilitate FDA review.
3. Estimated Timeline for Registration: Varies; new drug applications can take several months to years.
4. Import Tariff/Duty for HS 30049011: Pharmaceutical products under this HS code are generally duty-free.
Philippines
1. Drug Regulatory Authority: Food and Drug Administration Philippines.
2. Import Registration Process: Requires submission of product dossiers, including Certificates of Product Registration and Good Manufacturing Practice certificates.
3. Estimated Timeline for Registration: Approximately 6-12 months.
4. Import Tariff/Duty for HS 30049011: Tariff rates vary; importers should consult the Philippine Tariff Commission for specific rates.
Hong Kong
1. Drug Regulatory Authority: Department of Health, Drug Office.
2. Import Registration Process: Importers must obtain a Certificate of Drug Registration, providing details on product quality and safety.
3. Estimated Timeline for Registration: Approximately 6-9 months.
4. Import Tariff/Duty for HS 30049011: Hong Kong maintains a free port status with no import tariffs on pharmaceutical products.
Demand Drivers & Market Opportunity
TransData Nexus Natural buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for "Natural" in importing countries is influenced by several factors:
1. Disease Prevalence: High incidence of conditions treatable by "Natural" drives demand. For example, in regions with prevalent neglected tropical diseases, access to essential medicines is crucial.
2. Government Healthcare Programs: Initiatives aimed at expanding universal health coverage (UHC) increase the need for essential medicines. Countries implementing UHC strive to ensure equitable access to quality healthcare, including essential medicines.
3. WHO Essential Medicines List Procurement: Inclusion of "Natural" in the WHO Essential Medicines List encourages procurement by governments and international organizations, ensuring availability in public health systems.
4. Tender-Based Purchasing: Many countries and organizations utilize tender systems for bulk purchasing of medicines, promoting competitive pricing and consistent supply. Effective public procurement procedures are essential for timely access to health technologies. (who.int)
With 742 buyers across 132 countries, the market for "Natural" demonstrates significant global reach and potential for growth, especially in regions prioritizing healthcare access and affordability.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 742 global importers of Natural identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 3,891 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 132 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,891 Verified Shipments
742 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists